The Integrity Tests: Choosing Diffusive Airflows of Bubble Points

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-01-2004
Volume 2004 Supplement
Issue 7

This article critiques the diffusive-airflow and bubble-point tests for their comparative suitability for integrity testing in pharmaceutical processes.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content